Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mesorectal Microbiome and Metabolome as a Prognostic Factor in Patients With Rectal Cancer and Analysis of it's Applicability in Neoadjuvant Treatment

NCT04804956 is registered in ClinicalTrials.gov with University Hospital of Girona Dr. Josep Trueta as lead sponsor.

NCT NCT04804956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04804956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mesorectal Microbiome and Metabolome as a Prognostic Factor in Patients With Rectal Cancer and Analysis of it's Applicability in Neoadjuvant Treatment
Lead sponsor
University Hospital of Girona Dr. Josep Trueta
Phase
Observational
Overall status
Recruiting
Start date
April 1, 2021
Completion date
April 1, 2028
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer